Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected Adults
Clinical trial NCT03945981 · COMPLETED
Trial details
- NCT number
- NCT03945981
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-02
- Primary completion
- 2020-04-29
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.